Ho, W. S., Wang, H., John, K., Maggio, D., Heiss, J., Gilbert, M. R., . . . Zhuang, Z. (2017). IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE. Neuro Oncol.

Ho, Winson SC, Herui Wang, Kovach John, Dominic Maggio, John Heiss, Mark R. Gilbert, Rongze Lu, i Zhengping Zhuang. "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE." Neuro Oncol 2017.

Ho, Winson SC, et al. "IMMU-55. PHARMACOLOGIC INHIBITION OF PROTEIN PHOSPHATASE-2A, WITH NOVEL INHIBITOR LB-100, ACHIEVES DURABLE IMMUNE-MEDIATED ANTITUMOR ACTIVITY WHEN COMBINED WITH PD1 BLOCKADE." Neuro Oncol 2017.